Status:
UNKNOWN
I-125 Seeds Loaded Stent Insertion for Inoperable Hilar Cholangiocarcinoma
Lead Sponsor:
Xuzhou Central Hospital
Conditions:
Hilar Cholangiocarcinoma
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Malignant biliary obstruction usually arise in patients suffering from primary or metastatic hepatobiliary tumors. Approximately 80% of malignant biliary obstruction patients are not eligible for surg...
Detailed Description
Malignant biliary obstruction usually arise in patients suffering from primary or metastatic hepatobiliary tumors. Approximately 80% of malignant biliary obstruction patients are not eligible for surg...
Eligibility Criteria
Inclusion
- Patients with a diagnosed hilar Cholangiocarcinoma; Inoperable cases; Patients showed evidence of obstructive jaundice; Eastern Cooperative Oncology Group performance status \< 4.
Exclusion
- Patients who underwent post-operative external radiotherapy; Patients in whom prior biliary stent insertion or drainage were performed; Patients suffering from serious dysfunction of the pulmonary, renal, cardiac, or coagulatory systems.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04779788
Start Date
April 1 2021
End Date
June 30 2022
Last Update
July 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuzhou Central Hospital
Xuzhou, Jiangsu, China, 221009